Trials / Active Not Recruiting
Active Not RecruitingNCT06425900
A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients
Histologic and Liquid Chromatography Mass Spectrometry (LCMS) Evaluation of the Sebaceous Gland Changes Induced by Clascoterone Cream 1%
- Status
- Active Not Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Sun Pharmaceutical Industries Limited · Industry
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
to compare facial sebaceous gland morphology after 3 months of clascoterone cream 1% treatment and to compare facial sebum constituents at baseline to facial sebum constituents after 3 months of clascoterone cream 1% treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Winlevi (Clascoterone) cream 1% | Dosed twice daily (BID) |
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2024-05-23
- Last updated
- 2026-01-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06425900. Inclusion in this directory is not an endorsement.